Recursion Pharmaceuticals Inc (RXRX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
2,005,654,000
EV to revenue ratio (TTM)
28.26
EV to ebitda
-5.31
Financial Performance
Revenue (TTM)
54,856,000
Gross profit (TTM)
-392,600,000
EBITDA
-471,604,000
Profitability
Operating margin (TTM)
-1,760.00%
Profit margin
0.00%
Return on assets (TTM)
-27.30%
Return on equity (TTM)
-56.60%
Per Share Metrics
Revenue per share (TTM)
0.11
EPS
-1
Diluted EPS (TTM)
-1
Book value
1.71
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
36.56
Price to book ratio (TTM)
2.168
Growth
Quarterly earnings growth (YoY)
-60.10%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
2
Buy
1
Hold
4
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.071